Drug Pipeline

TARA-002 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
1
Phase 3
1
Top Sponsors
4
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-19 NCT05951179
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With…		 Primary endpoint(s) modified
2026-05-19 NCT05951179
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With…		 Trial sites expanded: 61 -> 66 locations
2026-05-19 NCT05951179
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With…		 date change Primary completion pushed: 2030-05 -> 2031-10
2026-05-19 NCT05951179
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With…		 date change Completion pushed: 2030-08 -> 2032-03
Active Studies by Phase
Phase 3
1
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07480356 Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of… Bladder (Urothelial, Transitional Cell) Cancer Not Yet Recruiting
Phase 2
NCT05871970 Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic… Lymphatic Malformation Recruiting
NCT05951179 Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With… Non-muscle Invasive Bladder Cancer Recruiting
Sponsors Running TARA-002 Trials
Protara Therapeutics (3)
Disease Areas
Bladder Cancer (2)
Get alerts when TARA-002 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free